A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma
Pemigatinib, a pan-FGFR inhibitor, is approved to treat intrahepatic cholangiocarcinoma (ICC) harboring FGFR2 fusion mutations. Improving its targeting of FGFR2 fusions remains an unmet clinical need due to its pan selectivity and resistance. Here, we report a cholesterol-conjugated DNA/RNA heterodu...
में बचाया:
मुख्य लेखकों: | , , , , , , , , , , , |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
Elsevier,
2023-12-01T00:00:00Z.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
इंटरनेट
Connect to this object online.3rd Floor Main Library
बोधानक: |
A1234.567 |
---|---|
प्रति 1 | उपलब्ध |